controversies surrounding the management and treatment of lymphomas
Published 2 years ago • 194 plays • Length 1:16Download video MP4
Download video MP3
Similar videos
-
2:55
novel issues in the combined modality treatment of lymphomas
-
2:18
treating patients with advanced-stage hl in the frontline and relapsed settings in 2024
-
1:40
updates on the management of hodgkin lymphoma: early-stage disease vs advanced stage disease
-
1:36
the changing role of chemotherapy in lymphoma and the value of novel immunotherapies
-
6:24
tnb-486: interim results of a cd19/cd3 t-cell engager in r/r follicular lymphoma
-
2:19
novel treatment options for non-hodgkin lymphoma
-
2:29
signs and symptoms of lymphoma - mayo clinic
-
1:54
navigating regulatory challenges in developing and approving therapies for rare lymphomas
-
1:29
updates on the diagnosis, risk stratification and management of hl
-
2:39
advancements in bispecific and trispecific antibodies for the treatment of lymphoma
-
2:42
the current role of chemotherapy in the treatment of hodgkin lymphoma & the impact of novel agents
-
2:03
novel therapeutic agents in the treatment of hodgkin and non-hodgkin lymphoma
-
4:58
overview of the toxicities associated with bispecific agents in multiple myeloma
-
1:27
diagnosis and risk stratification in hodgkin lymphoma: updates and novel approaches
-
1:16
the importance of multidisciplinary collaboration in the classification of lymphomas
-
3:04
applying molecular understanding of dlbcl to management strategies
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
0:36
the potential of immunotherapies in the myeloma treatment landscape
-
5:02
treatment of lymphoma: overview of the continued progress
-
2:38
car-t therapy for aggressive b-cell lymphomas
-
1:20
improving patient outcomes in ctcl: clinical collaboration and novel agents